VMD Sciences launches international veterinary access portal at WSAVA 2026

VMD Sciences introduced VMD Access International at the WSAVA World Congress in Warsaw to help veterinarians explore regulated pathways to animal health products across markets. The portal centralizes more than 3,000 products and links users to essential-medicine lists used across 180-plus countries.

Why it matters: - VMD Access International is designed to help veterinarians find treatment options when local access is limited. - The portal focuses on established, compliant import-export pathways rather than informal sourcing. - VMD Sciences says the goal is to make global treatment access more connected, transparent and achievable.

What happened: - VMD Sciences unveiled VMD Access International at the 51st WSAVA World Congress in Warsaw, Poland, held Oct. 13-15, 2026. - Licensed veterinarians and pharmacists can request an account starting Oct. 13. - WSAVA attendees can sign up at VMD Sciences booth #152 in Hall 4. - CEO and founder Jeff Oliva and Veterinary Innovations Specialist Kamryn Shaughnessy, M.S., are attending the congress.

The details: - The portal gives veterinary professionals a centralized resource for exploring more than 3,000 products. - The catalog includes drugs and biologics approved elsewhere in the world. - The platform covers companion animals, livestock, equine and exotic species. - VMD Access International includes compliant access to WSAVA, WOAH, WVA and Brooke lists of essential medicines. - Those organizations represent more than 500,000 veterinarians across more than 180 countries. - The essential medicines lists are modeled after the World Health Organization's human framework. - The lists identify core drugs needed for preventive care and treatment of the most common and urgent diseases. - VMD Sciences says product availability and export eligibility vary by product and destination. - All requests remain subject to U.S. export rules, destination-country laws and other applicable requirements. - The platform does not guarantee product availability or import eligibility. - VMD Sciences also allows visitors to learn about VMD Access (U.S.) at the booth. - More information is available on the company's website. - The company also lists social media pages on LinkedIn, Instagram, Facebook, X, and another LinkedIn page.

Between the lines: - VMD Sciences is positioning the portal as a regulatory and logistical tool, not a shortcut around approval rules. - The emphasis on essential-medicine lists suggests the company is targeting urgent gaps in access, not just broad product browsing. - The launch at WSAVA puts the product in front of a global audience of veterinary professionals already focused on care access and international standards.

What's next: - Veterinarians and pharmacists can begin requesting accounts immediately. - The company is using WSAVA to recruit users and explain how the portal fits into existing compliance pathways. - Availability will depend on product, destination and regulatory approval.